Biote Medical Overview

  • Year Founded
  • 2012

Year Founded

  • Status
  • Public

  • Employees
  • 223

Employees

  • Stock Symbol
  • BTMD

Stock Symbol

  • Investments
  • 3

  • Share Price
  • $1.06
  • (As of Friday Closing)

Biote Medical General Information

Description

Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary components to enable Biote-certified practitioners to establish, build, and successfully implement a program designed to optimize hormone levels using personalized solutions for their patient populations. The company provides support to medical practitioners through training, practice development, and operational services to establish and manage hormone therapy centers. Its activities include educating practitioners on identifying and treating hormone-related conditions. The company generates revenues by charging the Biote-partnered clinics fees associated with the Biote Method and from the sale of Biote-branded dietary supplements.

Contact Information

Website
www.biote.com
Ownership Status
Publicly Held
Financing Status
Corporation
Corporate Office
  • 1875 West Walnut Hill Lane
  • Suite 100
  • Irving, TX 75038
  • United States
+1 (844)
Primary Industry
Pharmaceuticals
Other Industries
Other Healthcare Services
Stock Exchange
NAS
Corporate Office
  • 1875 West Walnut Hill Lane
  • Suite 100
  • Irving, TX 75038
  • United States
+1 (844)

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Biote Medical Stock Performance

As of 13-Nov-2026, Biote Medical’s stock price is $1.06. Its current market cap is $28.8M with 27M shares.

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$1.06 $1.03 $0.99 - $2.90 $28.8M 27M 186K -$0.07

Biote Medical Financials Summary

As of 30-Sep-2026, Biote Medical has a trailing 12-month revenue of $179M.

In Thousands,
USD
TTM 30-Sep-2026 FY 2025 31-Dec-2025 FY 2024 31-Dec-2024 FY 2023 31-Dec-2023
EV 159,770 165,412 279,875 187,653
Revenue 178,909 192,219 197,191 185,360
EBITDA 15,840 52,215 15,647 9,234
Net Income (1,925) 27,045 3,157 3,316
Total Assets 101,696 107,613 122,370 155,295
Total Debt 127,825 109,922 110,862 114,871
Public Fundamental Data provided by Morningstar, Inc. disclaimer

Biote Medical Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Biote Medical‘s full profile, request access.

Request a free trial

Biote Medical Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Biote Corp operates a growth practice-building business within the hormone optimization space. It provides the necessary
Pharmaceuticals
Irving, TX
223 As of 2025

Scottsdale, AZ
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Biote Medical Competitors (1)

One of Biote Medical’s competitors is The SottoPelle Group, a Corporation company based in Scottsdale, AZ.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
The SottoPelle Group Corporation Scottsdale, AZ
You’re viewing 1 of 1 competitors. Get the full list »

Biote Medical Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Biote Medical Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Biote Medical‘s full profile, request access.

Request a free trial

Biote Medical Investments & Acquisitions (3)

Biote Medical’s most recent deal was a Merger/Acquisition with Asteria Health for . The deal was made on 18-Mar-2024.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Asteria Health 18-Mar-2024 Merger/Acquisition Pharmaceuticals
Simpatra (Portfolio of Intellectual Property Rights) 02-Jan-2024 Corporate Asset Purchase Buildings and Property
Haymaker Acquisition III 26-May-2022 Merger/Acquisition Special Purpose Acquisition Company (SPAC)
To view Biote Medical’s complete investments and acquisitions history, request access »

Biote Medical ESG

Risk Overview

Risk Rating

Updated November, 04, 2026

33.7 | High Risk

Risk Scale

A lower score indicates better sustainability

Negl

0-10

Low

10-20

Med

20-30

High

30-40

Severe

40+

Exposure

Exposure refers to the extent to which a company is exposed to different material ESG issues

Management

Management is related to actions taken to manage ESG issues

Peers Analysis

Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.

Global

Covered Companies

of 13,592

Rank

Percentile

Healthcare

Industry

of 590

Rank

Percentile

Medical Facilities

Subindustry

of 117

Rank

Percentile

To view Biote Medical’s complete esg history, request access »

Biote Medical Affiliates

Subsidiaries (1)

Name Industry Location Year Founded
Asteria Health Birmingham, AL 2017

Biote Medical FAQs

  • When was Biote Medical founded?

    Biote Medical was founded in 2012.

  • Where is Biote Medical headquartered?

    Biote Medical is headquartered in Irving, TX.

  • What is the size of Biote Medical?

    Biote Medical has 223 total employees.

  • What industry is Biote Medical in?

    Biote Medical’s primary industry is Pharmaceuticals.

  • Is Biote Medical a private or public company?

    Biote Medical is a Public company.

  • What is Biote Medical’s stock symbol?

    The ticker symbol for Biote Medical is BTMD.

  • What is the current stock price of Biote Medical?

    As of 13-Nov-2026 the stock price of Biote Medical is $1.06.

  • What is the current market cap of Biote Medical?

    The current market capitalization of Biote Medical is $28.8M.

  • What is Biote Medical’s current revenue?

    The trailing twelve month revenue for Biote Medical is $179M.

  • Who are Biote Medical’s competitors?

    The SottoPelle Group is a competitor of Biote Medical.

  • What is Biote Medical’s annual earnings per share (EPS)?

    Biote Medical’s EPS for 12 months was -$0.07.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process